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Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the
emergence of autoreactive Tcells. Humans and mice with SLE have reduced numbers of
CD1d-restricted invariant natural killer T (iNKT) cells, suggesting a key role for these
cells in its immunopathogenesis. This subset uses an invariant TCR constituted by
Va14Ja281 chains paired with some Vb domains. The regulatory role for iNKT cells in
non-autoimmune mice was suggested by our previous results showing that aged Ja281
knockout (KO) mice produce anti-dsDNA. Here we show that old Ja281 KO mice have
proteinuria and antibodies against dsDNA and cardiolipin. Histological analysis of
Ja281 KOmice revealed glomeruli damage and deposition of C3c and IgG, mainly of the
IgG3 subclass. In spleens of aged Ja281 KO mice there is an increase of activated
marginal zone B cells. The evolution of lesions may depend on the age-associated
increase of autoantibodies production, preferentially IgG3, mainly secreted by marginal
zone B cells. Our results provide the first evidence of a lupus-like syndrome in non-
autoimmune mice, supporting an age-related immunoregulatory role of Ja281+ cells,
probably associated with the activation of marginal zone B cells.
Introduction
Systemic lupus erythematosus (SLE, lupus) is an
autoimmune disease characterized by the loss of
tolerance to a variety of self antigens. Development of
SLE is associated with the emergence of autoreactive Th
cells [1–4] accompanied by a reduction of regulatory
T cells [5–7]. However, the nature and specificity of
regulatory T cells that inhibit autoantibodies production
and development of lupus remain largely undefined.
Some regulatory T cells that are cd Tcells or VH peptide-
reactive CD8+ Tcells have been reported to be capable of
inhibiting autoantibodies secretion by ablating auto-
reactive B cells[3, 7]. Recent reports show that humans
and mice with lupus and related autoimmune diseases
have reduced numbers of invariant natural killer T
(iNKT) cells [8–11], and that their number recovers
during the improvement in disease activity [10]. These
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observations suggest that iNKT cells may be an essential
part of a possible regulatory T cell network that inhibits
the induction of SLE.
Murine iNKT cells coexpress NK cell markers (e.g.,
CD161) and T cell markers (i.e., an invariant Va14Ja281
TCR chain paired predominantly with Vb8 chains) and
are mostly CD4+ or double negative. They recognize, in
association with CD1d [12], an endogenous ligand [13],
which is mimicked by a glycolipid, a-galactosylceramide
(a-GalCer) [12, 14, 15]. CD1d-reactive iNKTcells, which
can be traced using a-GalCer/CD1d tetramers [16–19],
appear to play protective roles against a variety of
immune-mediated conditions, including autoimmune
diabetes [20–22].
NZB/NZW F1 and MRL-lpr/lpr mice, which sponta-
neously develop autoantibodies and nephritis, are useful
models for studying the pathogenesis of SLE [2, 3, 4, 7,
23, 24]. Recently, the introduction of induced models of
lupus, generated in otherwise normal mouse strains by
exposure to hydrocarbon oils such as pristane, has
promoted further investigations on the mechanisms
responsible for the outcome of SLE [25, 26]. Mechan-
isms by which pristane induces lupus-like autoimmunity
are poorly understood. In CD1d KO mice with BALB/c
background [27], the enhanced effect of CD1d defi-
ciency on the development of nephritis, autoantibodies
production, and cytokine responses was shown in
pristane-treated animals [26]. The previous study
indicates that CD1d deficiency exacerbates pristane-
induced lupus and that pristane inoculation in CD1d-
sufficient mice numerically and functionally suppresses
CD1d-expressing DC and iNKT cells. In addition, CD1d
deficiency enhances the numbers of marginal zone (MZ)
B cells, which are crucial for autoantibodies production
[28]. These findings suggest an immunoregulatory role
for CD1d-restricted T cells in lupus [28]. In lupus prone
strains, the immunoregulatory activity of iNKT cells
varied over their life-time, revealing a marked increase
in the potential of these cells to contribute to the
production of IFN-c with advancing age [29].
Since autoantibodies secretion increases with age in
CD1d KOmice (S. A. Porcelli, personal communication),
we speculate that it could be useful to study renal
functions and autoantibodies production in aged Ja281
KO mice lacking iNKT cells, to test if this cell subset is
also responsible for the regulation of autoimmune
response in not lupus-prone mice. Our findings provide
the first evidence that Ja281+ cell deficiency is
associated with an increased autoantibodies secretion
and the development of autoimmune kidney damage.
Results
Development of lupus-like nephritis in Ja281 KO
mice
To determine whether iNKT cells are involved in the
development of age-associated lupus-like nephritis, we
analyzed renal function in C57BL/6 and BALB/c Ja281
KO and wild-type mice. We tested 20 sex-matched mice
per group at 12 and 24 months of age. Proteinuria was
more severe in aged Ja281 KO mice than in the control
littermates (Fig. 1A, B), independently from the genetic
background. At 12 months, 50% of Ja281 KO mice
developed mild proteinuria, whereas in the wild type
only 40% had this grade of proteinuria on either the
C57BL/6 (Fig. 1A) or BALB/c background (Fig. 1B).
The frequency of moderate to severe proteinuria was
high (80%) at 24 months of age in C57BL/6 (Fig.1A, left
panel) and in BALB/c (Fig. 1B, left panel) Ja281 KO
mice. None of the wild-type mice developedmoderate or
severe proteinuria at 24 months (p=0.0001). Blood
urea nitrogen (BUN) was also elevated in old Ja281 KO
mice (Fig. 1C, D), suggesting an advanced renal disease;
80% of Ja281 KO mice but none of the wild-type mice
had elevated BUN (>15 mg/100 mL, p=0.002). Of the
Ja281 KO mice, 20% had a severely elevated BUN levels
(>30 mg/100 mL). Here again no significant differ-
ences were seen between the BALB/c and the C57BL/6
genetic background. Fig. 1E and F show the results of
survival of aged Ja281 KO compared to wild-type mice:
while 80% of aged Ja281 KO died within month 28 only
20% of wild-type mice died before 30 months.
At 24 months of age, when renal function is severely
compromised in Ja281 KOmice, animals were killed and
renal histology was analyzed in sections obtained from
ten kidneys per group (Fig. 2A, B). Mild and focal
mesangioproliferative glomerulonephritis was found in
60% of wild-type mice, 40% of wild-type mice had no
evidence of nephritis by light microscopy, and none of
the wild-type mice had evidence of diffuse proliferative
or chronic lesions. However, of the Ja281 KO mice, 50%
developed diffuse proliferative glomerulonephritis with
fibrous crescents, glomerulosclerosis, tubular atrophy
and interstitial fibrosis, 25% showed mild to moderate
mesangioproliferative lesions, and the remaining 25% of
these mice had mild focal or no lesions. The composite
kidney biopsy score (KBS) was increased in Ja281 KO
mice (p<0.05). Further histological analysis revealed an
increase in glomerular activity score (GAS) as well as in
chronic lesions score (CLS) in Ja281 KO animals.
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Ja281 cell deficiency is associated with
autoantibody production
It has been observed that anti-dsDNA production
increases in CD1d KO mice with age (S. A. Porcelli,
personal communication). We studied IgG anti-dsDNA
in sera obtained from 24-month-old C57BL/6 and
BALB/c Ja281 KO mice. Results shown in Fig. 3A
represent the mean of ten tested mice. Aged C57BL/6 or
BALB/c Ja281 KO mice had six- to sevenfold more anti-
dsDNA thanwild-type mice. As anti-dsDNA antibodies in
lupus-prone strains were frequently associated with high
levels of IgG anti-cardiolipin (CL), we tested sera of aged
mice (24 months) for the presence of IgG anti-CL
(Fig. 3B). Independently from the genetic background,
Ja281 KOmice developed 13-fold more anti-CL IgG than
age-matched wild-type mice. Moreover, anti-nuclear
antibodies were increased in sera of aged Ja281 KOmice
when compared to sera of wild-type mice (data not
shown).
Thus, compromised renal functions and histological
features correlate with increased anti-dsDNA and anti-
CL in aged Ja281 KO mice, suggesting that the lack of
Ja281+ cells may cause the expansion and activation of
B cells producing autoantibodies.
IgG and C3c deposition in glomeruli of Ja281 KO
mice
Previously reported data suggest that aged Ja281 KO
mice develop a lupus-like nephritis, probably due to
autoantibodies deposition. To confirm this hypothesis,
Figure 2. Kidney histology in aged Ja281 KO mice. (A)
Comparison of histological scores between ten kidneys
obtained from 24-month-old wild-type and ten Ja281 KO
BALB/c mice. (B) Data obtained in wild-type and Ja281 KO
C57BL/6mice. Individual components (GAS, TIAS, andCLS) and
a composite KBS (see the Materials and methods) in 24-month-
old mice are shown as the mean  SE scores (*, p<0.05, Mann-
Whitney U test).
Figure 1. Ja281 cell deficiency accelerates nephritis in aged
mice. C57BL/6 (A) and BALB/c (B) Ja281 KO (n=20) and wild-type
mice (n=20) were monitored for proteinuria. Results are shown
as the percentage of mice with 0+ to 4+ proteinuria at 12 and
24 months (0+, 0 mg/100 mL; 1+, 30 mg/100 mL; 2+, 100 mg/
100 mL; 3+, 300 mg/100 mL; and 4+, >2000 mg/100 mL). In (C)
and (D) BUN levels in 24-month-old Ja281 KO(n=20) and wild-
type (n=20) mice were shown. Results are shown as the
percentage of mice with normal (1+, 5–15 mg/100 mL) or
elevated (2+, 15–26 mg/100 mL and 3+, 30–40 mg/100 mL)
BUN. In (E) and (F) percentages of survival were recorded
comparing groups of 20 Ja281 KO and wild-type C57BL/6 (E) or
BALB/cmice (F). Survival was detected from 20 to 30 months of
age.
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we tested kidney sections of old Ja281 KO mice to
investigate IgG deposition. A common feature of each
strains analyzed was the expansion of mesangial area
due to aging. Fig. 4A shows glomerulosclerosis asso-
ciated with hypertrophy and increasing cell numbers in
Ja281 KO kidneys (panels II and IV), while only the
mesangial area is expanded in glomeruli of aged wild-
type mice (panels I and III). Glomerulosclerosis is
accompanied by immunoglobulin deposition, as shown
in panel VI, while no IgG deposition was detected in
wild-type mice (panel V). To characterize antigen
specificity of IgG present in the glomeruli, anti-dsDNA
IgG assays in kidney eluates of Ja281 KO and wild-type
mice were performed. As shown in Table 1, anti-dsDNA
IgG were found in glomeruli of aged Ja281 KO mice,
whereas these autoantibodies were undetectable in
kidney eluates of wild-type mice. A deeper immunohis-
Figure 4. IgG3 and C3c deposition in glomeruli of aged Ja281 KOmice. (A) Kidney sections of aged Ja281 KO andwild-type C57BL/6
mice were stained by H&E methods and analyzed by light microscope at 10 and 40magnification. Four representative photos
are shown to describe damaged glomeruli (I, II, III and IV). FITC-labeled anti-mouse-IgG was added to slides to find
immunoglobulin deposition in damaged glomeruli (40 magnification) (V and VI). Similar results were obtained in BALB/c
background mice. (B) Kidney sections of aged Ja281 KO and wild-type C57BL/6 mice were stained by H&E and analyzed by light
microscope at 40 magnification. FITC-labeled anti-mouse-IgG, IgG1, IgG2a, IgG2b, IgG3 and C3c were added to slides to detect
subclasses of IgG and C3c deposition in glomeruli (40 magnification).
Figure 3. Anti-dsDNA and anti-CL autoantibodies in aged Ja281
KOmice.SerawereobtainedfromagedC57BL/6andBALB/cwild-
typeandJa281KOmice(24 months).Anti-dsDNA(A)andanti-CL
(B) IgG were assessed by ELISA as described in theMaterials and
Methods. Data from individual mice and means are reported in
the graphics. Statistical comparison from experimental and
control groups was done using Student's t-test.
Table 1. Anti-IgG detected in renal eluates of aged mice
Samples Anti-dsDNA IgG (lg/g tissue)a)
Ja281 KO BALB/C 0.12
BALB/C N.D.b)
Ja281 KO C57BL/6 0.12
C57BL/6 N.D.
a) The concentration of anti-dsDNA IgG are expressed as lg/g
of kidneys for renal eluates.
b) N.D.: not detectable.
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tochemical analysis of glomeruli of aged Ja281 KO and
wild-typemice was shown in Fig. 4B. Glomeruli of Ja281
KO mice were brightly stained by anti-mouse IgG and a
similar staining was obtained using anti-mouse C3c and
IgG3, but not anti-IgG1, -IgG2a and -IgG2b. Instead, no
staining was detected in glomeruli of wild-type mice.
Expansion of MZ B cells in Ja281 KO mice
In conditions of NKT cell deficiency such as in CD1dKO
and pristane-injected wild-type mice, the lack of NKT
cell-mediated regulation of MZ B cells may result in
expansion and activation of this subset of B cells, which
is enriched in autoreactive cells [30].These cells secrete
mainly IgG3 autoantibodies [30]. A role of these B cells
in the development of lupus was suggested [30]. To test
if MZ B cells secreting IgG3 are present in aged Ja281 KO
mice, we performed cytofluorimetric analysis to test if
MZ B cells are expanded and/or activated in Ja281 KO
mice. The results reported in Fig. 5 show that B220+
CD21 high CD23 low cells, a phenotype corresponding to
MZ B cells [30], were increased by fourfold (Fig. 5A) in
the aged Ja281 KO mice when compared to wild-type
mice, regardless of the genetic background of mice.
Moreover, a significant proportion of the expanded MZ
B cells in aged Ja281 KOmice expressed CD69 (Fig. 5 B)
and CD25 (Fig. 5C), indicating that they were in an
activated status. Additionally, while serum IgG1 and
IgG2a levels were similar between the Ja281 KO and
control animals (data not shown), serum levels of IgG3
isotype were significantly increased in Ja281 KOmice as
compared towild-typemice (Fig. 5D). Interestingly, sera
of Ja281 KO mice had anti-dsDNA IgG3 antibody levels
greater than those detected in aged wild-type mice
(Fig. 5E). This evidence suggests that, in aged mice,
Ja281+ cells regulate the activation of MZ B cells that
secrete IgG3, which is the main subclass of autoantibody
produced in this experimental model.
Discussion
In this paper we report that lupus-like nephritis, which is
absent in aged BALB/c and C57BL/6mice, is quite severe
in Ja281 KO mice. Anti-dsDNA and anti-CL antibodies
are detected in Ja281 KO but not in wild-type mice. The
exacerbation of disease activity could be associated with
the expansion of MZ B cells, responsible for the
production of autoantibodies. Our observations suggest
a regulatory role of CD1d-restricted cells and support
the possibility that their depletion or reduction in
functions may be responsible for lupus development.
Indeed, patients with lupus and other systemic auto-
immune diseases have reduced numbers of iNKT cells
[9–11]. The NK/iNKT cell lineage marker, CD161, is
significantly decreased in the peripheral blood cells of
patients with SLE, as revealed in a recent gene
expression study [31]. Importantly, in humans, lupus
disease activity appears to inversely correlate with the
number of circulating iNKT cells [10].
The present study indicates that the immunoregu-
latory function exerted by iNKT cells is evident in aged
mice. It has been previously reported that a-GalCer-
mediated function of iNKT cells is age-dependently up-
regulated [32]. This is partially attributable to the fact
that systemic responses to a-GalCer are correlated with
age-dependent increase of the number of liver mono-
nuclear cells, even if the proportion of iNKT cells does
not differ between young and old mice [33]. It is
unknown why the ligand-mediated function of iNKT
cells is enhanced in age-dependent manner; however, it
Figure 5. Effect of Ja281 deficiency on MZ B cells. (A) Ja281 KO
andwild-type aged (24 months old)mice on BALB/c and C57BL/
6 background were killed and their spleen cells were stained
with B220, CD21 and CD23 and analyzed by flow cytometry. MZ
B cells (B220+CD21highCD23low) are shown as percentages in
spleen cells. Results represent three independent experiments
(n=2–4 mice/group). Percentages of CD69+ (B) and CD25+ (C)
cells after gating on B220+ CD21high CD23low were detected by
FACS analysis, and results reported are the means of three
different experiments. (D) Serum total IgG3 levels (mean  SE,
lg/mL) in aged Ja281 KO and wild-type C57BL/6 and BALB/c
mice were tested (n=13–16 mice/group, p<0.02). (E) Serum IgG3
anti-dsDNA antibody levels (mean  SE, lg/mL) were tested in
old Ja281 KO and wild-type C57BL/6 and BALB/c mice (n=13–16
mice/group, p<0.02).
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is possible that iNKTcells strengthen their function with
age to survey malignant tumors, activated normal cells,
and microbial infections.
Old CD1d KO BALB/c mice (>1.5 years old) have
also increased serum anti-dsDNA antibody levels as
compared with age-matched controls (S. A. Porcelli,
personal communication). A more direct evidence of
Ja281+ cell involvement in the regulation of lupus-like
disease comes from our study in which aged C57BL/6 or
BALB/c Ja281 KO mice have elevated anti-dsDNA, anti-
CL autoantibodies and renal IgG3 and C3c deposition. In
MRL-lpr/lpr mice, however, CD1d deficiency does not
lead to either worse kidney damage or increases in anti-
dsDNA antibody production [34]. The regulatory effects
of CD1d-restricted events on nephritis may require
intact Fas signaling, which is absent inMRL-lpr/lprmice,
or the anti-apoptotic effects of mutant Fas ligand are
able to bypass the role of CD1d-reactive T cells.
Furthermore, mechanisms of tissue damage seem to
be different among the clinical manifestations of lupus
in the same or in different animal models of lupus[35,
36], which probably represent several subsets of this
heterogeneous disease in humans. For example, the
correlation between the presence of anti-dsDNA-
antibodies and kidney disease found in mouse strains
was detected in almost 50% of patients affected by SLE
with these clinical manifestations [37]. It is, therefore,
not surprising that different mechanisms may operate in
the development of lupus in various animal models.
Some functionally distinct subsets of iNKT cells could
promote autoimmune responses [35] while others could
inhibit autoimmune disease[38, 39]. For example,
implantation of transgenic T cells expressing TCR-a
and –b chain genes from a T cell clone, which is CD1d
specific but does not express the invariant Va14 NKT
TCR, induces a lupus-like disease in irradiated BALB/c
nude recipients, whereas another subset of CD1d-
reactive T cells prevents the development of lupus in
the same model [40].
Finally, MZ B cells are expanded and activated in
Ja281 KOmice and, in agreement with data in literature
[30], we found increased serum levels and anti-dsDNA
IgG3 in Ja281 KO mice. These observations lead us to
speculate that Ja281+ Tcells may regulate the expansion
and activation of MZ B cells via CD1d, which is highly
expressed on these cells. The lack of iNKT cell-mediated
regulation of MZ B cells may, in turn, result in the
expansion and activation of this subset of B cells, which
are enriched in autoreactive cells [30, 40]. Studies have
suggested a role of these B cells in the development of
lupus [30, 40].
In summary, Ja281+ cell deficiency in aged BALB/c
and C57BL/6 mice is associated with lupus-like disease,
presumably through one or more of the following
possible mechanisms: (i) decreased T cell production of
IL-4 along with stable IFN-c production; (ii) decreased
TNF-a production by T cells in the disease induction
phase; (iii) a decrease in DC subsets that participate in
the establishment of immune tolerance and regulation,
and (iv) an expansion and activation of MZ B cells
secreting autoantibodies. Our findings in aged Ja281 KO
mice with a non-autoimmune background may be
relevant to the understanding of immunopathogenetic
mechanisms of spontaneous age-related lupus develop-
ment. Patients with SLE also have a reduction in iNKT
cell numbers, which appear to correlate with lupus
disease activity [10]. Interestingly, it has been reported
that the iNKTcell ligand, a-GalCer, protects BALB/c and
SJL/J mice against pristane-induced lupus nephritis and
protects MRL-lpr/lpr mice against spontaneous inflam-
matory dermatitis [5].
We do not know if our findings are clinically relevant
in the analysis of age-associated lupus-like disease.
However, Peralbo et al. [41] found that, in humans,
ageing was associated with a significant decline in the
percentage and proliferative response of peripheral
blood iNKT cells. Given the important immunoregula-
tory role of iNKT cells, these alterations in their number
and function could contribute to the deleterious
autoimmune response in the elderly causing MZ B cell
expansion, increased autoantibody production and
lupus-like disease.
Taken together, these findings corroborate the
overall conclusion that Ja281 T cells play a suppressive
role in the age-related lupus-like nephritis. Further
studies on the role of these cells and mechanisms by
which they regulate the development of lupus nephritis
in experimental models could be very useful for a deeper
understanding of the pathogenesis of autoimmune
diseases.
Materials and methods
Mice
C57BL/6 and BALB/c mice were purchased from Harlan
Nossan (Correzzana, MI, Italy). Ja281-deficient mice were
generous gift of Prof. M. Taniguchi (RIKENResearch Center for
Allergy and Immunology, Yokohama City, Kanagawa, Japan).
Mice that lack the Ja281 gene segment are devoid of
Va14Ja281+ NKT cells while having the other lymphoid cell
lineages intact [42]. Homogeneous populations were estab-
lished by backcrossing heterozygous mice to C57BL/6 or
BALB/c mice for more than eight generations. The resultant
heterozygous mice were bred to obtain homozygotes [42]. In
each experiment, age- and sex-matched control mice were
used at 12–24 months of age.
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Assessment of lupus-like disease
Kidney damage was assessed in Ja281 KO and wild-type mice
[2, 7]. Proteinuria was measured on a 0–4+ scale using a
colorimetric assay strip for albumin (Albustix; Bayer, Elkhart,
IN): 0, absent; 1+, 30 mg/100 mL (mild); 2+, 100 mg/
100 mL (moderate); 3+, 300 mg/100 mL (severe); and 4+,
>2000 mg/100 mL (severe). BUN levels were measured by
impregnating Azostix strips (Bayer) with a drop of fresh blood
and using the following scale: 1+, 5–15 mg/100 mL (normal);
2+, 15–26 mg/100 mL (mild); and 3+, 30 mg/100 mL
(severe). Percentages of survival was assessed in groups of ten
mice from 20 to 30 months of age comparing surviving Ja281
KO versus control littermates.
Kidney histological analysis
Paraffin-embedded sections of kidney fixed in 4% parafor-
maldehyde were stained with hematoxylin and eosin (H&E),
periodic acid-Schiff, and Masson's trichrome. Stained sections
were scored for the following features on a 0–3 scale by three of
us in a blind fashion [28]: (i) GAS that included glomerular
proliferation, karyorrhexis, fibrinoid necrosis, cellular cres-
cents, inflammatory cells and hyaline deposits; (ii) TIAS that
included interstitial inflammation, tubular cell pyknosis,
nuclear activation, cell necrosis and cell flattening, and
epithelial cells or macrophages in tubular lumens; and (iii)
CLS that included glomerular scars, glomerulosclerosis,
fibrous crescents, tubular atrophy, and interstitial fibrosis.
The raw scores assigned by various readers were averaged to
obtain a mean score for each of the individual features. The
mean scores for individual features were summed to obtain the
three main scores (GAS, TIAS and CLS) and then all three
scores were summed to determine a composite KBS.
ELISA assay for detection of autoantibodies against
dsDNA
Plates (96 wells; Costar, Copenhagen, Denmark) were coated
with dsDNA obtained from calf thymus (100 lg/mL; Sigma-
Aldrich, Milan, Italy) overnight at 4C. After blocking of
nonspecific binding sites with 10% FCS, serum samples were
added. Bound antibodies were detected with alkaline phos-
phatase-conjugated goat anti-mouse IgG, IgG1, IgG2a and IgG3
(Fisher, Pittsburgh, PA). Reactions were colorimetrically
developed with p-nitrophenyl phosphate (Sigma-Aldrich)
and A405 was measured with an ELISA reader. Anti-dsDNA
antibody titers are expressed as units per milliliter using a
reference-positive standard of pooled serum from MRL-lpr/lpr
mice. To test anti-dsDNA IgG in kidney eluates and serum anti-
dsDNA IgG3 absorbances of samples were compared to a
standard curve of mouse IgG and IgG3 from 100 to 0.1 lg/mL
using dsDNA-coated plates.
ELISA assay for detection of CL antibodies
Each well of a polystyrene microtiter plate (96-well; Luxlon,
Nemours, France) was coated with 50 lL bovine heart CL
(10 lg/mL) diluted in absolute ethanol. The plate was
incubated overnight at 4C to allow the alcohol to evaporate.
After blocking with 10% FCS, the plate was washed with PBS
and incubated with sera diluted in FCS. The plate was washed
three times and then incubated with alkaline phosphatase-
conjugated goat anti-mouse IgG (Rockland, Gilbertsville, PA).
Positive mouse sera were defined as those giving an A405
reading greater than the mean value plus 2 SD of sera from 60
normal control male mice. Results were reported as last
dilution of sera that were scored as positive using criteria
previously described.
ELISA assay for detection of serum IgG3
To determine the concentration of IgG3, ELISA plates were
coated with isotype-specific polyclonal antibody (Southern
Biotechnology Associates or Bethyl Laboratories, Birmingham,
AL) in carbonate buffer, pH 9.5. HRP-conjugated isotype-
specific polyclonal antibodies were used for detection of IgG3
(Southern Biotechnology Associates and Bethyl Laboratories).
Concentrations of IgG3 were determined using OptEIA kit and
with pair of IgG3-specific mAbs (BD Pharmingen, San Diego,
CA). Tetramethylbenzidine was used as a substrate (KPG
Laboratories). Absorbance at 450 nM was determined in an
ELISA reader (Molecular Devices), at a sensitivity of 1 lg/mL.
To test anti-dsDNA IgG3, sera were added to dsDNA coated
plates. Anti-dsDNA IgG3were detected as previously described.
Immunohistochemistry
Tissue samples were fixed in 4% buffered formalin and paraffin
embedded. Samples were cut at 5-lM thickness, stained with
H&E, and examined by light microscope (Olympus, Hamburg,
Germany). To detect IgG subclasses and/or C3c in sections
prepared as previously described, sections were dewaxed,
rehydrated and permeabilized using PBS, 0.1% Triton X-100
(Sigma, St. Louis, MO). Slides were then incubated with FITC-
conjugated goat anti-mouse IgG, IgG1, IgG2a, IgG3 and C3c
following procedures suggested by manufacturer (Sigma,
MO). Slides were analyzed by fluorescence microscope
(Olympus).
Antibody elution from kidneys
Kidney tissue of ten mice per group was weighed, pooled,
minced and collected in 500 lL PBS containing protease
inhibitor cocktail (Roche, Mannheim, Germany). The mixture
was centrifuged at 3000 rpm. for 5 min, and supernatants
were collected. Pellets were washed and resuspended in
250 lL elution buffer consisting of 01 M glycine-HCl, 015 M
NaCl, pH 25 and sonicated directly (Branson, Boom, Meppel,
The Netherlands) on ice, with three bursts of 30 s, followed by
overnight rotation at 4C. Samples were centrifuged for 10 min
at 10 000 rpm; supernatants were adjusted to pH 70. For
further analysis, all samples were standardized based on their
initial weight.
Analysis of splenic MZ B cells
Mice were killed by CO2 asphyxiation. Spleens were removed
aseptically, and RBC were lysed with ammonium chloride.
Spleen cells were washed with PBS-1% FCS, pH 7.2 buffer, and
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Fc receptors were blocked with antibody against CD16/32
(clone 93; BioLegend, San Diego, CA). The
B220+CD21highCD23– subset (MZ B cells) was detected by
staining spleen cells from Ja281 KO and wild-type mice with
FITC-labeled anti-CD21 (clone 7E9, eBioscience, San Diego,
CA), PE-labeled anti-CD23 (clone B3B4, eBioscience), PE-
labeled Cy7 anti-B220 (clone RA3–6B2, eBioscience) and by
gating on B220+CD23–CD21bright (MZ-B cells). To detect
activation markers, MZ B cells were stained using APC-labeled
CD25 (Clone PC61.5, eBioscience) or allophycocyanin-labeled
CD69 (Clone H1.2F3, eBioscience). Stained cells were
analyzed on a FACScan (BD Biosciences, San Diego, CA).
Data were processed using CellQuest software (BD Bios-
ciences).
Statistical analysis
Levels of antibodies and renal scores were compared using
Student's t- or Mann-Whitney U test. Proteinuria and BUN
grades were compared using the two-sided Fisher's exact test.
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